Antifungal agents: an overview. Part I.
The last decade has witnessed remarkable advances in the therapy for cutaneous fungal diseases. These will have a major impact on the choice of antifungal therapy. To understand these advances traditional therapies for fungal diseases, the polyenes, griseofulvin, older topical agents and the older azoles, will be reviewed first. Part II will focus on recent advances.
Gupta
A K
AK
Department of Medicine, Sunnybrook Health Science Centre, Toronto, Ontario, Canada.
Sauder
D N
DN
Shear
N H
NH
D000279:Administration, Cutaneous; D000284:Administration, Oral; D000935:Antifungal Agents / Q000008:administration & dosage / Q000145:classification / Q000627:therapeutic use*; D001393:Azoles / Q000008:administration & dosage / Q000627:therapeutic use; D003881:Dermatomycoses / Q000188:drug therapy*; D006801:Humans; D011090:Polyenes / Q000008:administration & dosage / Q000627:therapeutic use
D000935:Antifungal Agents; D001393:Azoles; D011090:Polyenes